Dr Reddy\'s Labs Q1 net seen down 24% at Rs 137.4 cr

is to announce its Q1FY09 numbers (US GAAP). According to CNBC-TV18 estimates, its net profit is seen going down 24% at Rs 137.4 crore in Q1 as against Rs 182.50 crore YoY. Net sales is likely to go up 19% Rs 1433.50 crore from Rs 1201.5 crore. Operating profit is likely to go up at Rs 224 crore from Rs 206.50 crore and operating profit margin is seen down at 15.7% versus 17.18%. Factors to watch for Sales growth on account of consolidation of recently acquired Dow's CRAM's Facility in UK and BASF's US facility Sales to grow on account of growth in branded formulations business OPMs to be impacted due to higher R&D costs, worsening margins of Betapharm on account of price cuts and supply shortages Await clarity on CPS... [read full story]